Multimodal therapy in the treatment of carcinoma of the uterine cervix

E. A. Case, Frederick Stehman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

What is the best treatment for patients with locally advanced cervical cancer? Radiation therapy with external beam and brachytherapy implants has long been the standard in North America. Much investigation has been conducted regarding treatment of this disease, and researchers have demonstrated the importance of appropriate scheduling, dosing, and field design. The authors of five recently published randomized clinical trials strongly suggest that radiation with concurrent chemotherapy that utilizes cisplatin should be the new treatment standard for patients with locally advanced cervical cancer. Carcinoma of the uterine cervix remains a major health problem for women worldwide. In the United States, early detection of cervical cancer has been made possible by the development of Papanicolaou's smear, which has significantly reduced the mortality associated with the disease. Still, there will be 12,900 American women diagnosed with invasive cervical cancer in 2001. Most of these cancers will be found in women who had not been screened regularly. In addition, cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America.

Original languageEnglish
Pages (from-to)323-328
Number of pages6
JournalOncology Spectrums
Volume2
Issue number5
StatePublished - 2001

Fingerprint

Cervix Uteri
Uterine Cervical Neoplasms
Carcinoma
Therapeutics
Papanicolaou Test
Neoplasms
South America
Brachytherapy
Women's Health
North America
Early Detection of Cancer
Cisplatin
Radiotherapy
Randomized Controlled Trials
Research Personnel
Radiation
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Health Policy

Cite this

Multimodal therapy in the treatment of carcinoma of the uterine cervix. / Case, E. A.; Stehman, Frederick.

In: Oncology Spectrums, Vol. 2, No. 5, 2001, p. 323-328.

Research output: Contribution to journalArticle

@article{d07f8c3bf9df4b2086823e9d97bc9069,
title = "Multimodal therapy in the treatment of carcinoma of the uterine cervix",
abstract = "What is the best treatment for patients with locally advanced cervical cancer? Radiation therapy with external beam and brachytherapy implants has long been the standard in North America. Much investigation has been conducted regarding treatment of this disease, and researchers have demonstrated the importance of appropriate scheduling, dosing, and field design. The authors of five recently published randomized clinical trials strongly suggest that radiation with concurrent chemotherapy that utilizes cisplatin should be the new treatment standard for patients with locally advanced cervical cancer. Carcinoma of the uterine cervix remains a major health problem for women worldwide. In the United States, early detection of cervical cancer has been made possible by the development of Papanicolaou's smear, which has significantly reduced the mortality associated with the disease. Still, there will be 12,900 American women diagnosed with invasive cervical cancer in 2001. Most of these cancers will be found in women who had not been screened regularly. In addition, cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America.",
author = "Case, {E. A.} and Frederick Stehman",
year = "2001",
language = "English",
volume = "2",
pages = "323--328",
journal = "Oncology Spectrums",
issn = "1532-8554",
number = "5",

}

TY - JOUR

T1 - Multimodal therapy in the treatment of carcinoma of the uterine cervix

AU - Case, E. A.

AU - Stehman, Frederick

PY - 2001

Y1 - 2001

N2 - What is the best treatment for patients with locally advanced cervical cancer? Radiation therapy with external beam and brachytherapy implants has long been the standard in North America. Much investigation has been conducted regarding treatment of this disease, and researchers have demonstrated the importance of appropriate scheduling, dosing, and field design. The authors of five recently published randomized clinical trials strongly suggest that radiation with concurrent chemotherapy that utilizes cisplatin should be the new treatment standard for patients with locally advanced cervical cancer. Carcinoma of the uterine cervix remains a major health problem for women worldwide. In the United States, early detection of cervical cancer has been made possible by the development of Papanicolaou's smear, which has significantly reduced the mortality associated with the disease. Still, there will be 12,900 American women diagnosed with invasive cervical cancer in 2001. Most of these cancers will be found in women who had not been screened regularly. In addition, cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America.

AB - What is the best treatment for patients with locally advanced cervical cancer? Radiation therapy with external beam and brachytherapy implants has long been the standard in North America. Much investigation has been conducted regarding treatment of this disease, and researchers have demonstrated the importance of appropriate scheduling, dosing, and field design. The authors of five recently published randomized clinical trials strongly suggest that radiation with concurrent chemotherapy that utilizes cisplatin should be the new treatment standard for patients with locally advanced cervical cancer. Carcinoma of the uterine cervix remains a major health problem for women worldwide. In the United States, early detection of cervical cancer has been made possible by the development of Papanicolaou's smear, which has significantly reduced the mortality associated with the disease. Still, there will be 12,900 American women diagnosed with invasive cervical cancer in 2001. Most of these cancers will be found in women who had not been screened regularly. In addition, cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America.

UR - http://www.scopus.com/inward/record.url?scp=0034958855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034958855&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034958855

VL - 2

SP - 323

EP - 328

JO - Oncology Spectrums

JF - Oncology Spectrums

SN - 1532-8554

IS - 5

ER -